| Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. S Meri, BP Morgan, A Davies, RH Daniels, MG Olavesen, H Waldmann, ... Immunology 71 (1), 1, 1990 | 702 | 1990 |
| Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation MK Liszewski, M Kolev, G Le Friec, M Leung, PG Bertram, AF Fara, ... Immunity 39 (6), 1143-1157, 2013 | 593 | 2013 |
| Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. S Meri, MK Pangburn Proceedings of the National Academy of Sciences 87 (10), 3982-3986, 1990 | 545 | 1990 |
| Membranoproliferative glomerulonephritis type II (dense deposit disease): an update GB Appel, HT Cook, G Hageman, JC Jennette, M Kashgarian, ... Journal of the American Society of Nephrology 16 (5), 1392-1403, 2005 | 520 | 2005 |
| The effects of type 2 diabetes mellitus on organ metabolism and the immune system G Daryabor, MR Atashzar, D Kabelitz, S Meri, K Kalantar Frontiers in immunology 11, 1582, 2020 | 500 | 2020 |
| Complement activation after oxidative stress: role of the lectin complement pathway CD Collard, A Väkevä, MA Morrissey, A Agah, SA Rollins, WR Reenstra, ... The American journal of pathology 156 (5), 1549-1556, 2000 | 481 | 2000 |
| The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi J Hellwage, T Meri, T Heikkilä, A Alitalo, J Panelius, P Lahdenne, ... Journal of Biological Chemistry 276 (11), 8427-8435, 2001 | 474 | 2001 |
| Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome T Manuelian, J Hellwage, S Meri, J Caprioli, M Noris, S Heinen, M Jozsi, ... The Journal of clinical investigation 111 (8), 1181-1190, 2003 | 407 | 2003 |
| New approaches to the treatment of dense deposit disease RJH Smith, J Alexander, PN Barlow, M Botto, TL Cassavant, HT Cook, ... Journal of the American Society of Nephrology 18 (9), 2447-2456, 2007 | 348 | 2007 |
| Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms. A Harjunpää, S Junnikkala, S Meri Scandinavian journal of immunology 51 (6), 634-641, 2000 | 347 | 2000 |
| Molecular genetic characterization of the Fennoscandian cervid strain, a new genotypic group (G10) of Echinococcus granulosus A Lavikainen, MJ Lehtinen, T Meri, V Hirvelä-Koski, S Meri Parasitology 127 (3), 207-215, 2003 | 327 | 2003 |
| Factor H family proteins: on complement, microbes and human diseases PF Zipfel, C Skerka, J Hellwage, ST Jokiranta, S Meri, V Brade, P Kraiczy, ... Biochemical Society Transactions 30 (6), 971-978, 2002 | 320 | 2002 |
| Each of the three binding sites on complement factor H interacts with a distinct site on C3b TS Jokiranta, J Hellwage, V Koistinen, PF Zipfel, S Meri Journal of Biological Chemistry 275 (36), 27657-27662, 2000 | 301 | 2000 |
| Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein M Laine, H Jarva, S Seitsonen, K Haapasalo, MJ Lehtinen, N Lindeman, ... The Journal of Immunology 178 (6), 3831-3836, 2007 | 300 | 2007 |
| Immune evasion of tumor cells using membrane-bound complement regulatory proteins A Gorter, S Meri Immunology today 20 (12), 576-582, 1999 | 300 | 1999 |
| Membrane proteins that protect against complement lysis BP Morgan, S Meri Springer seminars in immunopathology 15, 369-396, 1994 | 297 | 1994 |
| Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration … GS Hageman, LS Hancox, AJ Taiber, KM Gehrs, DH Anderson, ... Annals of medicine 38 (8), 592-604, 2006 | 277 | 2006 |
| Dual interaction of factor H with C3d and glycosaminoglycans in host–nonhost discrimination by complement T Kajander, MJ Lehtinen, S Hyvärinen, A Bhattacharjee, E Leung, ... Proceedings of the National Academy of Sciences 108 (7), 2897-2902, 2011 | 269 | 2011 |
| The factor H protein family PF Zipfel, TS Jokiranta, J Hellwage, V Koistinen, S Meri Immunopharmacology 42 (1-3), 53-60, 1999 | 264 | 1999 |
| Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. S Meri, V Koistinen, A Miettinen, T Törnroth, IJ Seppälä Journal of Experimental Medicine 175 (4), 939-950, 1992 | 262 | 1992 |
